CANAGLIFLOZIN vs CANAKINUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
CANAGLIFLOZIN vs CANAKINUMAB: Safety Overview
| Metric | CANAGLIFLOZIN | CANAKINUMAB |
|---|---|---|
| Total FAERS Reports | 24,411 | 10,462 |
| Deaths Reported | 544 | 518 |
| Death Rate | 2.2% | 5.0% |
| Hospitalizations | 9,503 | 2,624 |
| Average Patient Age | 57.8 yrs | 28.8 yrs |
| % Female Patients | 49.1% | 55.8% |
| FDA Approval Date | Mar 29, 2013 | N/A |
| Manufacturer | Cardinal Health 107, LLC | Novartis Pharmaceuticals Corporation |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |